Search research articles
Contact Us
Filters
Showing results (31-40 of 88) with videos related to
Page
of 9
Sort By:
Antibodies (Basel, Switzerland)
|
December 11, 2019
Understanding Inter-Individual Variability in Monoclonal Antibody Disposition
Veena A Thomas, Joseph P Balthasar
Journal of Pharmacokinetics and Pharmacodynamics
|
December 26, 2013
Predicting the effects of 8C2, a monoclonal anti-topotecan antibody, on plasma and tissue disposition of topotecan
Dhaval K Shah, Joseph P Balthasar
Journal of Pharmacokinetics and Pharmacodynamics
|
November 25, 2010
Physiologically based pharmacokinetic model for topotecan in mice
Dhaval K Shah, Joseph P Balthasar
Journal of Immunoassay & Immunochemistry
|
May 3, 2016
Development and validation of an enzyme-linked immunosorbent assay for the quantification of gelonin in mouse plasma
Frank A Engler, Joseph P Balthasar
Bioconjugate Chemistry
|
July 22, 2022
Cell Penetrating Peptides Conjugated to Anti-Carcinoembryonic Antigen "Catch-and-Release" Monoclonal Antibodies Alter Plasma and Tissue Pharmacokinetics in Colorectal Cancer Xenograft Mice
Joseph Ryan Polli, Joseph P Balthasar
Mabs
|
November 29, 2016
Physiologically-based modeling to predict the clinical behavior of monoclonal antibodies directed against lymphocyte antigens
Patrick M Glassman, Joseph P Balthasar
Journal of Pharmaceutical Sciences
|
May 23, 2003
Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia
Ryan J Hansen, Joseph P Balthasar
Journal of Pharmaceutical Sciences
|
July 30, 2005
Application of anti-methotrexate Fab fragments for the optimization of intraperitoneal methotrexate therapy in a murine model of peritoneal cancer
Evelyn D Lobo, Joseph P Balthasar
International Journal of Pharmaceutics
|
February 2, 2013
Application of knockout mouse models to investigate the influence of FcγR on the pharmacokinetics and anti-platelet effects of MWReg30, a monoclonal anti-GPIIb antibody
Lubna Abuqayyas, Xiaoyan Zhang, Joseph P Balthasar
Journal of Pharmacokinetics and Pharmacodynamics
|
September 22, 2007
Mathematical modeling of topotecan pharmacokinetics and toxicodynamics in mice
Jin Chen, Qiang Lu, Joseph P Balthasar
Page
of 9
Search research articles
Search
Showing results (31-40 of 88) with videos related to
Sort By:
Page
of 9
Antibodies (Basel, Switzerland)
|
December 11, 2019
Understanding Inter-Individual Variability in Monoclonal Antibody Disposition
Veena A Thomas, Joseph P Balthasar
Journal of Pharmacokinetics and Pharmacodynamics
|
December 26, 2013
Predicting the effects of 8C2, a monoclonal anti-topotecan antibody, on plasma and tissue disposition of topotecan
Dhaval K Shah, Joseph P Balthasar
Journal of Pharmacokinetics and Pharmacodynamics
|
November 25, 2010
Physiologically based pharmacokinetic model for topotecan in mice
Dhaval K Shah, Joseph P Balthasar
Journal of Immunoassay & Immunochemistry
|
May 3, 2016
Development and validation of an enzyme-linked immunosorbent assay for the quantification of gelonin in mouse plasma
Frank A Engler, Joseph P Balthasar
Bioconjugate Chemistry
|
July 22, 2022
Cell Penetrating Peptides Conjugated to Anti-Carcinoembryonic Antigen "Catch-and-Release" Monoclonal Antibodies Alter Plasma and Tissue Pharmacokinetics in Colorectal Cancer Xenograft Mice
Joseph Ryan Polli, Joseph P Balthasar
Mabs
|
November 29, 2016
Physiologically-based modeling to predict the clinical behavior of monoclonal antibodies directed against lymphocyte antigens
Patrick M Glassman, Joseph P Balthasar
Journal of Pharmaceutical Sciences
|
May 23, 2003
Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia
Ryan J Hansen, Joseph P Balthasar
Journal of Pharmaceutical Sciences
|
July 30, 2005
Application of anti-methotrexate Fab fragments for the optimization of intraperitoneal methotrexate therapy in a murine model of peritoneal cancer
Evelyn D Lobo, Joseph P Balthasar
International Journal of Pharmaceutics
|
February 2, 2013
Application of knockout mouse models to investigate the influence of FcγR on the pharmacokinetics and anti-platelet effects of MWReg30, a monoclonal anti-GPIIb antibody
Lubna Abuqayyas, Xiaoyan Zhang, Joseph P Balthasar
Journal of Pharmacokinetics and Pharmacodynamics
|
September 22, 2007
Mathematical modeling of topotecan pharmacokinetics and toxicodynamics in mice
Jin Chen, Qiang Lu, Joseph P Balthasar
Page
of 9